1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Interval Debulking: new trials by email Literature Review of Interval Debulking trials Research Report on Interval Debulking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy AVB-S6-500, Paclitaxel, Carboplatin - Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma | Phase 1 | Withdrawn | Washington University School of Medicine | 2021-06-30 | 2021-09-29 |
Carcinoma, Ovarian Epithelial (1) · Fallopian Tube Neoplasms (1)
Washington University School of Medicine (1)